Explore the latest Editors’ picks from Journal of Antimicrobial Chemotherapy (JAC) and JAC-Antimicrobial Resistance (JAC-AMR). This month, two different studies look at the effect of COVID-19 on antimicrobial prescribing, therapeutic drug monitoring reveals the importance of considering obesity in ceftazidime dosing, and a survey of students in Zambia highlights high levels of self-medication with antibiotics. Also, find out how cholesterol-lowering drugs could help to treat invasive fungal infections.

Understanding Antimicrobial Resistance (AMR) and the drivers for its development will help healthcare professionals work together to reduce its emergence and spread. It is well documented that the more we use antimicrobial agents, the more drug resistance will develop. Many National Dental Organisations* have come together to support the World AMR Awareness Week theme “Preventing Antimicrobial Resistance Together”.

The Global Health Network and British Society for Antimicrobial Chemotherapy (BSAC) have signed a Memorandum of Understanding (MoU) establishing a framework for collaboration that can maximise the impact of shared antimicrobial resistance education, policy and advocacy efforts.

Explore the latest Editors’ picks from Journal of Antimicrobial Chemotherapy (JAC) and JAC-Antimicrobial Resistance (JAC-AMR). In JAC, we have support for a new, shorter treatment regimen for visceral leishmaniasis, safety trial results for a new antifungal treatment and a report on remdesivir treatment for COVID-19 patients. And in JAC-AMR, 10 years of data from Peru show a worrying increase in resistance to shigellosis treatments and a report finds reduced cefiderocol activity in Pseudomonas aeruginosa with treatment-emergent resistance to ceftolozane/tazobactam.

Now in its second year, the BSAC Parliamentary Internship Programme offers a unique opportunity for two PhD students to work at the intersection of science and policy in the Office of Baroness Natalie Bennett. Following the success of our first cohort, we are pleased to announce our two new BSAC-funded interns: Lorna Flintham, and Katy Stokes.

Following the successful accreditation of 10 hospitals joining our Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS) in 2023, BSAC is excited to announce that we have opened applications for hospitals wishing to join the next tranche of GAMSAS clients starting the process in early 2024.

As one of the first centres in the world to be accredited via BSAC’s Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS), Lagos University Teaching Hospital, in Lagos, Nigeria, has received major news coverage in their home country, with their success reported by the Nigerian Television Authority (NTA).

BSAC is excited to announce the next tranche of hospitals that have been accredited via the Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS) and congratulates the following hospitals on their achievements: